Publications

Found 8 results
Filters: Author is C. Casartelli  [Clear All Filters]
2012
A. C. Custódio, Almeida, L. O., Pinto, G. R., Santos, M. J., Almeida, J. R. W., Clara, C. A., Rey, J. A., and Casartelli, C., Variation in DNA repair gene XRCC3 affects susceptibility to astrocytomas and glioblastomas, vol. 11, pp. 332-339, 2012.
Andreassi MG, Foffa I, Manfredi S, Botto N, et al. (2009). Mutation research/fundamental and molecular mechanisms of mutagenesis. Mutat. Res. 666: 57-63. http://dx.doi.org/10.1016/j.mrfmmm.2009.04.003 PMid:19393248 Collins VP (2004). Brain tumours: classification and genes. J. Neurol. Neurosurg. Psychiatry 75 (Suppl 2): ii2-11. http://dx.doi.org/10.1136/jnnp.2004.040337 PMid:50411 Curran JE, Lea RA, Rutherford S, Weinstein SR, et al. (2001). Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer. Int. J. Cancer 95: 271-275. http://dx.doi.org/10.1002/1097-0215(20010720)95:4<271::AID-IJC1046>3.0.CO;2-D Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, et al. (2001). High-resolution haplotype structure in the human genome. Nat. Genet. 29: 229-232. http://dx.doi.org/10.1038/ng1001-229 PMid:11586305 Gabriel SB, Schaffner SF, Nguyen H, Moore JM, et al. (2002). The structure of haplotype blocks in the human genome. Science 296: 2225-2229. http://dx.doi.org/10.1126/science.1069424 PMid:12029063 Griffin CS and Thacker J (2004). The role of homologous recombination repair in the formation of chromosome aberrations. Cytogenet. Genome Res. 104: 21-27. http://dx.doi.org/10.1159/000077462 PMid:15162011 Hartmann C, Mueller W and von Deimling A (2004). Pathology and molecular genetics of oligodendroglial tumors. J. Mol. Med. 82: 638-655. http://dx.doi.org/10.1007/s00109-004-0565-9 PMid:15322700 Hirai M, Suzuki S, Hinokio Y, Yamada T, et al. (2005). WRN gene 1367 Arg allele protects against development of type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 69: 287-292. http://dx.doi.org/10.1016/j.diabres.2005.01.012 PMid:16098926 Ichimura K, Ohgaki H, Kleihues P and Collins VP (2004). Molecular pathogenesis of astrocytic tumours. J. Neurooncol. 70: 137-160. http://dx.doi.org/10.1007/s11060-004-2747-2 PMid:15674475 Ino Y, Betensky RA, Zlatescu MC, Sasaki H, et al. (2001). Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin. Cancer Res. 7: 839-845. PMid:11309331 Jacobsen NR, Raaschou-Nielsen O, Nexo B, Wallin H, et al. (2004). XRCC3 polymorphisms and risk of lung cancer. Cancer Lett. 213: 67-72. http://dx.doi.org/10.1016/j.canlet.2004.04.033 PMid:15312685 Jara L, Dubois K, Gaete D, de Mayo T, et al. (2010). Variants in DNA double-strand break repair genes and risk of familial breast cancer in a South American population. Breast Cancer Res. Treat. 122: 813-822. http://dx.doi.org/10.1007/s10549-009-0709-2 PMid:20054644 Jeffreys AJ, Kauppi L and Neumann R (2001). Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex. Nat. Genet. 29: 217-222. http://dx.doi.org/10.1038/ng1001-217 PMid:11586303 Jiao L, Hassan MM, Bondy ML, Wolff RA, et al. (2008). XRCC2 and XRCC3 gene polymorphism and risk of pancreatic cancer. Am. J. Gastroenterol. 103: 360-367. http://dx.doi.org/10.1111/j.1572-0241.2007.01615.x PMid:17986315    PMCid:2268638 Kiuru A, Lindholm C, Heinavaara S, Ilus T, et al. (2008). XRCC1 and XRCC3 variants and risk of glioma and meningioma. J. Neurooncol. 88: 135-142. http://dx.doi.org/10.1007/s11060-008-9556-y PMid:18330515 Kleihues P, Louis DN, Scheithauer BW, Rorke LB, et al. (2002). The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol. 61: 215-225. PMid:11895036 Lee SA, Lee KM, Park SK, Choi JY, et al. (2007). Genetic polymorphism of XRCC3 Thr241Met and breast cancer risk: case-control study in Korean women and meta-analysis of 12 studies. Breast Cancer Res. Treat. 103: 71-76. http://dx.doi.org/10.1007/s10549-006-9348-z PMid:17063279 Lin RC, Wang XL and Morris BJ (2003). Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant. Obes. Res. 11: 802-808. http://dx.doi.org/10.1038/oby.2003.111 PMid:12805402 Loizidou MA, Michael T, Neuhausen SL, Newbold RF, et al. (2008). Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. Breast Cancer Res. Treat. 112: 575-579. http://dx.doi.org/10.1007/s10549-007-9881-4 PMid:18188695 Louis DN, Pomeroy SL and Cairncross JG (2002). Focus on central nervous system neoplasia. Cancer Cell 1: 125-128. http://dx.doi.org/10.1016/S1535-6108(02)00040-5 Matullo G, Palli D, Peluso M, Guarrera S, et al. (2001). XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32) P-DNA adducts in a sample of healthy subjects. Carcinogenesis 22: 1437-1445. http://dx.doi.org/10.1093/carcin/22.9.1437 PMid:11532866 McCormack BM, Miller DC, Budzilovich GN, Voorhees GJ, et al. (1992). Treatment and survival of low-grade astrocytoma in adults - 1977-1988. Neurosurgery 31: 636-642. http://dx.doi.org/10.1227/00006123-199210000-00004 PMid:1407448 Miller RD and Kwok PY (2001). The birth and death of human single-nucleotide polymorphisms: new experimental evidence and implications for human history and medicine. Hum. Mol. Genet. 10: 2195-2198. http://dx.doi.org/10.1093/hmg/10.20.2195 PMid:11673401 Ng HK and Lam PY (1998). The molecular genetics of central nervous system tumors. Pathology 30: 196-202. http://dx.doi.org/10.1080/00313029800169236 PMid:9643506 Ohgaki H (2005). Genetic pathways to glioblastomas. Neuropathology 25: 1-7. http://dx.doi.org/10.1111/j.1440-1789.2004.00600.x PMid:15822813 Ohgaki H and Kleihues P (2005). Epidemiology and etiology of gliomas. Acta Neuropathol. 109: 93-108. http://dx.doi.org/10.1007/s00401-005-0991-y PMid:15685439 Patil N, Berno AJ, Hinds DA, Barrett WA, et al. (2001). Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294: 1719-1723. http://dx.doi.org/10.1126/science.1065573 PMid:11721056 Phillips MS, Lawrence R, Sachidanandam R, Morris AP, et al. (2003). Chromosome-wide distribution of haplotype blocks and the role of recombination hot spots. Nat. Genet. 33: 382-387. http://dx.doi.org/10.1038/ng1100 PMid:12590262 Reich DE, Cargill M, Bolk S, Ireland J, et al. (2001). Linkage disequilibrium in the human genome. Nature 411: 199-204. http://dx.doi.org/10.1038/35075590 PMid:11346797 Simpson JR, Horton J, Scott C, Curran WJ, et al. (1993). Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int. J. Radiat. Oncol. Biol. Phys. 26: 239-244. http://dx.doi.org/10.1016/0360-3016(93)90203-8 Smith TR, Miller MS, Lohman K, Lange EM, et al. (2003). Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett. 190: 183-190. http://dx.doi.org/10.1016/S0304-3835(02)00595-5 Sreeja L, Syamala VS, Syamala V, Hariharan S, et al. (2008). Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J. Cancer Res. Clin. Oncol. 134: 645-652. http://dx.doi.org/10.1007/s00432-007-0328-4 PMid:17952468 Tamura K, Suzuki M, Arakawa H, Tokuyama K, et al. (2003). Linkage and association studies of STAT6 gene polymorphisms and allergic diseases. Int. Arch. Allergy Immunol. 131: 33-38. http://dx.doi.org/10.1159/000070432 PMid:12759487 Tebbs RS, Zhao Y, Tucker JD, Scheerer JB, et al. (1995). Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc. Natl. Acad. Sci. U. S. A. 92: 6354-6358. http://dx.doi.org/10.1073/pnas.92.14.6354 Thacker J (2005). The RAD51 gene family, genetic instability and cancer. Cancer Lett. 219: 125-135. http://dx.doi.org/10.1016/j.canlet.2004.08.018 PMid:15723711 Winsey SL, Haldar NA, Marsh HP, Bunce M, et al. (2000). A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res. 60: 5612-5616. PMid:11059748 Yamada Y, Ando F, Niino N and Shimokata H (2003). Association of polymorphisms of interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men. J. Clin. Endocrinol. Metab. 88: 3372-3378. http://dx.doi.org/10.1210/jc.2002-021449 Zhou K, Liu Y, Zhang H, Liu H, et al. (2009). XRCC3 haplotypes and risk of gliomas in a Chinese population: a hospital-based case-control study. Int. J. Cancer 124: 2948-2953. http://dx.doi.org/10.1002/ijc.24307 PMid:19330829
2011
A. C. Custódio, Almeida, L. O., Pinto, G. R., Santos, M. J., Almeida, J. R. W., Clara, C. A., Rey, J. A., and Casartelli, C., Analysis of the polymorphisms XRCC1Arg194Trp and XRCC1Arg399Gln in gliomas, vol. 10, pp. 1120-1129, 2011.
Au WW, Salama SA and Sierra-Torres CH (2003). Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ. Health Perspect. 111: 1843-1850. doi:10.1289/ehp.6632 PMid:14630517    PMCid:1241747 Caldecott KW (2003). XRCC1 and DNA strand break repair. DNA Repair 2: 955-969. doi:10.1016/S1568-7864(03)00118-6 Collins VP (2004). Brain tumours: classification and genes. J. Neurol. Neurosurg. Psychiatr. 75 (Suppl 2): ii2-11. doi:10.1136/jnnp.2004.040337 PMid:50411 Curran JE, Lea RA, Rutherford S, Weinstein SR, et al. (2001). Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer. Int. J. Cancer 95: 271-275. doi:10.1002/1097-0215(20010720)95:4<271::AID-IJC1046>3.0.CO;2-D Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, et al. (2001). High-resolution haplotype structure in the human genome. Nat. Genet. 29: 229-232. doi:10.1038/ng1001-229 PMid:11586305 Felini MJ, Olshan AF, Schroeder JC, North KE, et al. (2007). DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology 29: 55-58. doi:10.1159/000108919 PMid:17898525 Gabriel SB, Schaffner SF, Nguyen H, Moore JM, et al. (2002). The structure of haplotype blocks in the human genome. Science 296: 2225-2229. doi:10.1126/science.1069424 PMid:12029063 Goode EL, Ulrich CM and Potter JD (2002). Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomark. Prev. 11: 1513-1530. PMid:12496039 Hartmann C, Mueller W and von Deimling A (2004). Pathology and molecular genetics of oligodendroglial tumors. J. Mol. Med. 82: 638-655. doi:10.1007/s00109-004-0565-9 PMid:15322700 Hirai M, Suzuki S, Hinokio Y, Yamada T, et al. (2005). WRN gene 1367 Arg allele protects against development of type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 69: 287-292. doi:10.1016/j.diabres.2005.01.012 PMid:16098926 Hu Z, Ma H, Chen F, Wei Q, et al. (2005). XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol. Biomark. Prev. 14: 1810-1818. doi:10.1158/1055-9965.EPI-04-0793 Ichimura K, Ohgaki H, Kleihues P and Collins VP (2004). Molecular pathogenesis of astrocytic tumours. J. Neurooncol. 70: 137-160. doi:10.1007/s11060-004-2747-2 PMid:15674475 Improta G, Sgambato A, Bianchino G, Zupa A, et al. (2008). Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population. Anticancer Res. 28: 2941-2946. PMid:19031937 Ino Y, Betensky RA, Zlatescu MC, Sasaki H, et al. (2001). Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin. Cancer Res. 7: 839-845. PMid:11309331 Jeffreys AJ, Kauppi L and Neumann R (2001). Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex. Nat. Genet. 29: 217-222. doi:10.1038/ng1001-217 PMid:11586303 Jelonek K, Gdowicz-Klosok A, Pietrowska M, Borkowska M, et al. (2010). Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J. Appl. Genet. 51: 343-352. doi:10.1007/BF03208865 PMid:20720310 Kawabata M, Kawabata T and Nishibori M (2005). Role of recA/RAD51 family proteins in mammals. Acta Med. Okayama 59: 1-9. PMid:15902993 Kleihues P, Louis DN, Scheithauer BW, Rorke LB, et al. (2002). The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol. 61: 215-225. PMid:11895036 Ladiges WC (2006). Mouse models of XRCC1 DNA repair polymorphisms and cancer. Oncogene 25: 1612-1619. doi:10.1038/sj.onc.1209370 PMid:16550161 Li H, Ha TC and Tai BC (2009). XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis. Breast 18: 183-191. doi:10.1016/j.breast.2009.03.008 PMid:19446452 Lin RC, Wang XL, Dalziel B, Caterson ID, et al. (2003). Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant. Obes. Res. 11: 802-808. doi:10.1038/oby.2003.111 PMid:12805402 Loizidou MA, Michael T, Neuhausen SL, Newbold RF, et al. (2008). Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. Breast Cancer Res. Treat. 112: 575-579. doi:10.1007/s10549-007-9881-4 PMid:18188695 Louis DN, Pomeroy SL and Cairncross JG (2002). Focus on central nervous system neoplasia. Cancer Cell 1: 125-128. doi:10.1016/S1535-6108(02)00040-5 McCormack BM, Miller DC, Budzilovich GN, Voorhees GJ, et al. (1992). Treatment and survival of low-grade astrocytoma in adults - 1977-1988. Neurosurgery 31: 636-642. doi:10.1227/00006123-199210000-00004 PMid:1407448 Miller RD and Kwok PY (2001). The birth and death of human single-nucleotide polymorphisms: new experimental evidence and implications for human history and medicine. Hum. Mol. Genet. 10: 2195-2198. doi:10.1093/hmg/10.20.2195 PMid:11673401 Moullan N, Cox DG, Angele S, Romestaing P, et al. (2003). Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol. Biomark. Prev. 12: 1168-1174. PMid:14652276 Ng HK and Lam PY (1998). The molecular genetics of central nervous system tumors. Pathology 30: 196-202. doi:10.1080/00313029800169236 PMid:9643506 Ohgaki H (2005). Genetic pathways to glioblastomas. Neuropathology 25: 1-7. doi:10.1111/j.1440-1789.2004.00600.x PMid:15822813 Ohgaki H and Kleihues P (2005). Epidemiology and etiology of gliomas. Acta Neuropathol. 109: 93-108. doi:10.1007/s00401-005-0991-y PMid:15685439 Patil N, Berno AJ, Hinds DA, Barrett WA, et al. (2001). Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294: 1719-1723. doi:10.1126/science.1065573 PMid:11721056 Phillips MS, Lawrence R, Sachidanandam R, Morris AP, et al. (2003). Chromosome-wide distribution of haplotype blocks and the role of recombination hot spots. Nat. Genet. 33: 382-387. doi:10.1038/ng1100 PMid:12590262 Reich DE, Cargill M, Bolk S, Ireland J, et al. (2001). Linkage disequilibrium in the human genome. Nature 411: 199-204. doi:10.1038/35075590 PMid:11346797 Simpson JR, Horton J, Scott C, Curran WJ, et al. (1993). Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive radiation therapy oncology group (RTOG) clinical trials. Int. J. Radiat. Oncol. Biol. Phys. 26: 239-244. doi:10.1016/0360-3016(93)90203-8 Sreeja L, Syamala VS, Syamala V, Hariharan S, et al. (2007). Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J. Cancer Res. Clin. Oncol. 134: 645-652. doi:10.1007/s00432-007-0328-4 PMid:17952468 Sturgis EM, Castillo EJ, Li L, Zheng R, et al. (1999). Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 20: 2125-2129. doi:10.1093/carcin/20.11.2125 PMid:10545415 Tae K, Lee HS, Park BJ, Park CW, et al. (2004). Association of DNA repair gene XRCC1 polymorphisms with head and neck cancer in Korean population. Int. J. Cancer 111: 805-808. doi:10.1002/ijc.20338 PMid:15252855 Tamura K, Suzuki M, Arakawa H, Tokuyama K, et al. (2003). Linkage and association studies of STAT6 gene polymorphisms and allergic diseases. Int. Arch. Allergy Immunol. 131: 33-38. doi:10.1159/000070432 PMid:12759487 Wang LE, Bondy ML, Shen H, El-Zein R, et al. (2004). Polymorphisms of DNA repair genes and risk of glioma. Cancer Res. 64: 5560-5563. doi:10.1158/0008-5472.CAN-03-2181 PMid:15313891 Wang N, Dong XJ, Zhou RM, Guo W, et al. (2009). An investigation on the polymorphisms of two DNA repair genes and susceptibility to ESCC and GCA of high-incidence region in northern China. Mol. Biol. Rep. 36: 357-364. doi:10.1007/s11033-007-9187-y PMid:18046624 Yamada Y, Ando F, Niino N and Shimokata H (2003). Association of polymorphisms of interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men. J. Clin. Endocrinol. Metab. 88: 3372-3378. doi:10.1210/jc.2002-021449
2010
A. C. Custódio, Almeida, L. O., Pinto, G. R., Santos, M. J., Almeida, J. R. W., Clara, C. A., Rey, J. A., and Casartelli, C., GSTP1 Ile105Val polymorphism in astrocytomas and glioblastomas, vol. 9, pp. 2328-2334, 2010.
Collins VP (2004). Brain tumours: classification and genes. J. Neurol. Neurosurg. Psychiatry 75 (Suppl 2): ii2-ii11. http://dx.doi.org/10.1136/jnnp.2004.040337 PMid:15146033 PMCid:1765661   De Roos AJ, Rothman N, Inskip PD, Linet MS, et al. (2003). Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol. Biomarkers Prev. 12: 14-22. PMid:12540498   Ezer R, Alonso M, Pereira E, Kim M, et al. (2002). Identification of glutathione S-transferase (GST) polymorphisms in brain tumors and association with susceptibility to pediatric astrocytomas. J. Neurooncol. 59: 123-134. http://dx.doi.org/10.1023/A:1019601305210 PMid:12241105   Hartmann C, Mueller W and von Deimling A (2004). Pathology and molecular genetics of oligodendroglial tumors. J. Mol. Med. 82: 638-655. http://dx.doi.org/10.1007/s00109-004-0565-9 PMid:15322700   Ichimura K, Ohgaki H, Kleihues P and Collins VP (2004). Molecular pathogenesis of astrocytic tumours. J. Neurooncol. 70: 137-160. http://dx.doi.org/10.1007/s11060-004-2747-2 PMid:15674475   Ino Y, Betensky RA, Zlatescu MC, Sasaki H, et al. (2001). Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin. Cancer Res. 7: 839-845. PMid:11309331   Kabesch M, Hoefler C, Carr D, Leupold W, et al. (2004). Glutathione S transferase deficiency and passive smoking increase childhood asthma. Thorax 59: 569-573. http://dx.doi.org/10.1136/thx.2003.016667 PMid:15223862 PMCid:1747082   Kadouri L, Kote-Jarai Z, Hubert A, Baras M, et al. (2008). Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers. Br. J. Cancer 98: 2006-2010. http://dx.doi.org/10.1038/sj.bjc.6604394 PMid:18542066 PMCid:2441947   Kleihues P, Louis DN, Scheithauer BW, Rorke LB, et al. (2002). The WHO classification of tumors of the nervous system. J. Neuropathol. Exp. Neurol. 61: 215-225. PMid:11895036   Louis DN, Pomeroy SL and Cairncross JG (2002). Focus on central nervous system neoplasia. Cancer Cell 1: 125-128. http://dx.doi.org/10.1016/S1535-6108(02)00040-5   McCormack BM, Miller DC, Budzilovich GN, Voorhees GJ, et al. (1992). Treatment and survival of low-grade astrocytoma in adults - 1977-1988. Neurosurgery 31: 636-642. http://dx.doi.org/10.1227/00006123-199210000-00004 PMid:1407448   McLeish S and Turner SW (2007). Gene-environment interactions in asthma. Arch. Dis. Child 92: 1032-1035. http://dx.doi.org/10.1136/adc.2006.112185 PMid:17954484 PMCid:2083615   Millikan R, Pittman G, Tse CK, Savitz DA, et al. (2000). Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidemiol. Biomarkers Prev. 9: 567-573. PMid:10868690   Ng HK and Lam PY (1998). The molecular genetics of central nervous system tumors. Pathology 30: 196-202. http://dx.doi.org/10.1080/00313029800169236 PMid:9643506   Ohgaki H (2005). Genetic pathways to glioblastomas. Neuropathology 25: 1-7. http://dx.doi.org/10.1111/j.1440-1789.2004.00600.x PMid:15822813   Ohgaki H and Kleihues P (2005). Epidemiology and etiology of gliomas. Acta Neuropathol. 109: 93-108. http://dx.doi.org/10.1007/s00401-005-0991-y PMid:15685439   Okcu MF, Selvan M, Wang LE, Stout L, et al. (2004). Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin. Cancer Res. 10: 2618-2625. http://dx.doi.org/10.1158/1078-0432.CCR-03-0053 PMid:15102663   Reszka E, Wasowicz W and Gromadzinska J (2007). Antioxidant defense markers modulated by glutathione S-transferase genetic polymorphism: results of lung cancer case-control study. Genes Nutr. 2: 287-294. http://dx.doi.org/10.1007/s12263-007-0057-y PMid:18850183 PMCid:2474940   Ryberg D, Skaug V, Hewer A, Phillips DH, et al. (1997). Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18: 1285-1289. http://dx.doi.org/10.1093/carcin/18.7.1285 PMid:9230269   Saxena A, Dhillon VS, Raish M, Asim M, et al. (2009). Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population. Breast Cancer Res. Treat. 115: 537-543. http://dx.doi.org/10.1007/s10549-008-0098-y PMid:18574688   Schwartzbaum JA, Ahlbom A, Lonn S, Warholm M, et al. (2007). An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol. Biomarkers Prev. 16: 559-565. http://dx.doi.org/10.1158/1055-9965.EPI-06-0918 PMid:17372252   Simpson JR, Horton J, Scott C, Curran WJ, et al. (1993). Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int. J. Radiat. Oncol. Biol. Phys. 26: 239-244. http://dx.doi.org/10.1016/0360-3016(93)90203-8   Singh M, Shah PP, Singh AP, Ruwali M, et al. (2008). Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. Mutat. Res. 638: 184-194. http://dx.doi.org/10.1016/j.mrfmmm.2007.10.003 PMid:18035380   Syamala VS, Sreeja L, Syamala V, Raveendran PB, et al. (2008). Influence of germline polymorphisms of GSTT1, GSTM1, and GSTP1 in familial versus sporadic breast cancer susceptibility and survival. Fam. Cancer 7: 213-220. http://dx.doi.org/10.1007/s10689-007-9177-1 PMid:18080216   White DL, Li D, Nurgalieva Z and El-Serag HB (2008). Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am. J. Epidemiol. 167: 377-389. http://dx.doi.org/10.1093/aje/kwm315 PMid:18065725   Wideroff L, Vaughan TL, Farin FM, Gammon MD, et al. (2007). GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas. Cancer Detect. Prev. 31: 233-236. http://dx.doi.org/10.1016/j.cdp.2007.03.004 PMid:17646057 PMCid:2268246   Ye Z, Song H, Higgins JP, Pharoah P, et al. (2006). Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS Med. 3: e91. http://dx.doi.org/10.1371/journal.pmed.0030091 PMid:16509765 PMCid:1391981